Financial Interest Disclosure

Page directory

Program Committee Members and Abstract Graders

Moderators, Panelists, and Non-Member Speakers

Presenters

Educational Content Development

As the ACCME accredited provider for the ASRS 30th Annual Meeting, the American Society of Retina Specialists requires all Program committee members, abstract graders and any others in a position to control the educational content to disclose any commercial financial interests prior to the development of educational content. A process for resolution of conflict of interest is used for those committee members who do have financial interests related to the development of content.

Program committee members and abstract graders who fail to provide financial disclosures are not permitted to participate in the abstract grading process or the development of educational content.

Presenters

The ASRS considers financial relationships to create actual conflicts of interest when presenters of their immediate family (defined as spouse or domestic partner) have both a financial relationship with a commercial interest and the opportunity to affect ASRS policy or the content of CME about the products or services of that commercial interest. The potential for a presenter to maintain or increase the value of the financial relationship with the commercial interest creates an incentive to influence the content of the CME - an incentive to insert commercial bias.

All presenters of CME content should familiarize themselves with the ASRS Policy on Financial Disclosures and Resolution of Conflicts of Interest, which may be viewed in their entirety on the ASRS website at www.asrs.org. All ASRS members presenting CME are required to disclose to the activity audience the following information prior to beginning their presentation:

  • Any relevant financial relationships a CME presenter has had with manufacturers of commercial ophthalmic products or providers of commercial ophthalmic services within the past 12 months. The ASRS defines "relevant" financial relationships as those with a commercial ophthalmic interest and the opportunity to affect the content of CME about the products or services of that commercial ophthalmic interest. 
  • CME presenters who report they have no known relevant financial relationships to disclose will declare "No Financial Relationships." 

Note: All planners and teachers are required to report financial disclosures, using the codes below. Any planner/teacher not listed by name on the Financial Disclosure lists has informed the ASRS that they have no relevant financial disclosures to report. 

Description of Financial Interest


Types of Relationships 

A        Advisory Board
B        Board of Directions
C        Consultant
E        Employee
F        Founder
I         Investigator
SP     Speaker
SH    Stockholder
O      Other

Nature of Compensation
E        Equipment (dept or practice)
G       Grants
H       Honoraria
IP      Intellectual Property Rights
NC    No Compensation Received
OB    Other Financial Benefit
R        Royalty
RG    Residency or Fellowship Program Funding
S         Salary
ST      Stock
SO     Stock Options

Back to Top

Program Committee Members and Abstract Graders
Financial Interest or Relationship Disclosures
Carl C. Awh
Arctic DXA, C, SH/H, SO
Bausch+LombC, SP/H
KatalystA, SH/R, ST
GenentechC, I/G, H
SynergeticsA, C, SH/H, R
VolkC/H
ForSightC/H, SO
RegeneronC, I/H
Brett T. Foxman
GenentechI/OB
RegeneronI/OB
K. Bailey Freund
GenentechA/H
RegeneronA/H
QLT, IncA/H
AlimeraA/H
ThromboGenicsA/NC
OptosA/H
SequenomI/NC
Tarek S. Hassan
GenentechA, C/H
RegeneronA, C/H
EyetechA/H
QLTA, SP/NC
AllerganA/NC
Bausch & LombA, C/H
Insight InstrumentsC, O/H, IP
Arctic DxC, SH/SO
OptimedicaSH/SO
ThrombogenicsSP/NC
Suber S. Huang
SequenomA/H
Second SightC/H
Notal VisionC/H
Bausch &LombA/H
AlconSP/H
J. Michael Jumper
Covalent MedicalF/R
Mathew W. MacCumber
GenentechA, I/G, H
RegeneronA/H
AllerganA, I/G, H
OptosA, I/G, H
GlaxoSmithKlineI/G
William F. Mieler
GenentechC/H
AlconC/H
AllerganC/H
QLT/NovartisC/H
Alimera SciencesC/H
Andrew A. Moshfeghi
Genentech, Inc.A, C/H
Allergan, Inc.A, C/H
Alcon, Inc.A, C/H
Realm Global, LLCB/SO
Convene, LLCB, F/ST
Thrombogenics, Inc.A, C/H
Timothy G. Murray
AlconC/H
ThromboGenicsC/H
Dante Joseph Pieramici
GenentechA, C, I/G, H
ThrombogenicsA, I/G, H
AllerganI/G
AllimeraA, SP/H
Jonathan L. Prenner
OphthotechC, SH/OB, SO
PanopticaC/S
NeovistaC/SO
RegeneronC/S
GenentechC/S
NeurotechO/S
Steven D. Schwartz
GenentechA/G, H
OptosA/E
AllerganC/G
AlconC/H
Bausch & LombSP/H
Richard F. Spaide
TopconO/R
ThrombogenicsA/H
RegeneronO/G
John T. Thompson
GenentechI/G
Regeneron PharmaceuticalsI/G
Back to Top

Moderators, Panelists, and Non-Member Speakers
Financial Interest or Relationship Disclosures
Prema Abraham
LPathC/G
AlconC/G
AllerganC/G
GenentechC/G
RegeneronC/G
AlmeraC/G
SantenC/G
Thomas A. Albini
AlconC/H
AllerganC/H
Bausch + LombC/H
GenentechO/G
Robert L. Avery
alconC, I, SP/G, H
AllerganC, I/G, H
GenentechC, I, SP/G, H
NovartisC, SH/H, ST
Notal VisionC/H
OphthotechC/H
ReplenishA, C, SH/IP, R, ST
RegeneronC, SH/H, ST
AlexionSH/ST
QLTC/H
I-Tech JV Development, LLC SH/ST
Carl C. Awh
Arctic DXA, C, SH/H, SO
Bausch+LombC, SP/H
KatalystA, SH/R, ST
GenentechC, I/G, H
SynergeticsA, C, SH/H, R
VolkC/H
ForSightC/H, SO
RegeneronC, I/H
Abdhish R. Bhavsar
RegeneronA/H
GenentechI/G
DRCR.netI/G
David S. Boyer
alconA, C, I, SP/G, H
allerganA, C, I, SP/G, H
allegroA, SH/H
genentechC, I, SP/G, H
regeneronC, I/G, H
iCoC, I/NC
GSKC/H
NovartisC, I/G, H
BayerC/H
QuarkI/G
Neil M. Bressler
Abbott Medical Optics Inc.I/G
Alimera SciencesI/G
Allergan USA, Inc.I/G
Bausch & Lomb IncorporatedI/G
Bristol-Meyers Squibb CompanyI/G
Carl Zeiss Meditec, Inc.I/G
DIAGNOS INCI/G
ForSight Labs, LLCI/G
Genentech, Inc.I/G
Genzyme CorporationI/G
Lumenis, Inc.I/G
Notal VisionI/G
Novartis Pharma AGI/G
Optovue, Inc.I/G
Pfizer, Inc.I/G
Quark Biotech, Inc.I/G
Regeneron Pharmaceuticals, Inc.I/G
Research to Prevent BlindnessI/G
Steba Biotech S.A.I/G
The EMMES CorporationI/G
Susan B. Bressler
NovartisI/G
RegeneronI/G
Notal VisionI/G
Bausch + LombI/G
GenentechI/G
ThrombogenicsI/G
AllerganI/G
LumenisI/G
GlaxoSmithKlineC/H
David M. Brown
Genentech/RocheA, C, I/G, H
RegeneronA, C, I/G, H
AllerganA, C, I/G, H
AlconA, C, I/G, H
Steve T. Charles
Alcon LaboratoriesC/NC, R
Pravin U. Dugel
Abbott C/H
AlconC/H
AllerganC/H
Artic DxC, SH/H, ST
GenentechC/H
MacusightC, SH/H, ST
NeovistaC, SH/H, ST
ORA C/H
ThrombogenicsC/H
Regeneron C/H
Jay S. Duker
Hemera BiosciencesF/ST
OphthotechC/ST
EyeNetraC/ST
Paloma PharmaceuticalsA/NC
EMD/SeronoC/H
GenentechC/H
AlconC/H
RegeneronC/H
ThrombogenicsC/H
Carl Zeiss MeditechO/E
TopconO/E
OptoVueO/E
NeovistaA/H
NovartisC/H
QLTC/H
Philip J. Ferrone
AlconI/OB
AllerganI/OB
GenentechA, C, I, SP/H, OB
RegeneronSP/H
K. Bailey Freund
GenentechA/H
RegeneronA/H
QLT, IncA/H
AlimeraA/H
ThromboGenicsA/NC
OptosA/H
SequenomI/NC
Anne E. Fung
GenentechA, I/G, H
SantenA/H
ThrombogenicsA/H
AllerganA/H
SequenomA/H
Larry Halperin
Tarek S. Hassan
GenentechA, C/H
RegeneronA, C/H
EyetechA/H
QLTA, SP/NC
AllerganA/NC
Bausch & LombA, C/H
Insight InstrumentsC, O/H, IP
Arctic DxC, SH/SO
OptimedicaSH/SO
ThrombogenicsSP/NC
Jeffrey S. Heier
AcucelaC/OB
Alcon Laboratories, Inc.I/G
AlimeraI/G
Allergan, Inc.C, I/G, OB
Bausch LombC/OB
Bayer HealthcareC, I/G, OB
Endo Optiks, Inc.C/OB
Forsight LabsC/OB
Fovea PharmaceuticalsI/G
GENENTECHI/G
GenzymeC, I/G, OB
GlaxoSmithKlineI/G
Heidelberg EngineeringC/OB
Kato PharmaceuticalsC/OB
Lpath Inc.I/G
Neovista Inc.I/G
Notal VisionC, I/G, OB
Novartis Pharmaceuticals CorporationI/G
OpthotechC, I/G, OB
Paloma Inc.I/G
QLT OphthalmicsC/OB
RegeneronC, I/G, OB
SequenomC, I/G, OB
AerpioC, I/G, OB
Dutch OphthalmicC/OB
Kala PharmaceuticalsC/OB
KanghongC/OB
NicoxC/OB
Ohr PharmaceuticalC/OB
RocheC/OB
ThrombogenicsC/OB
XcoveryC/OB
Vertex PharmaceuticalsC/OB
Allen C. Ho
AlconA, C/H
AllerganI/G
JanssenC/G
GenentechC/G, H
PalomaC/H
PRNB/SO
RegeneronA/G, H
ThrombogenicsA, C/G, H
Suber S. Huang
SequenomA/H
Second SightC/H
Notal VisionC/H
Bausch &LombA/H
AlconSP/H
Mark S. Humayun
SECOND SIGHT MEDICAL PRODUCTSC, I, O/IP, ST
Rama D. Jager
OD-OSC/H
J. Michael Jumper
Covalent MedicalF/R
Peter K. Kaiser
NovartisC/G, H
RegeneronA, C/G, H
BayerA, C/H
SKS Ocular LLCB, F, SH/ST
Arctic DxA, C/H
OphthotechC/H
GenentechC/G, H
OrayaC/H
Bausch and LombA, C/H
AllegroA, C/H
AlimeraC/H
InSituC/H
Judy E. Kim
AllerganA/H
Alimera SciencesA/H
GenentechA/H
John W. Kitchens
GenentechC, I, SP/H
RegeneronA, SP/H
OptosC/H
SynergeticsA, C, SP/E, H
AllerganC/H
Baruch D. Kuppermann
AllerganA, C, I, SP/G, H
AllegroA, C/SO
AlimeraA, C, I/G, H
GenentechC, I/G, H
GlaxoSmithKlineI/G
NovagaliA, C/H
NeovistaC/H
ThrombogenicsA, C, I/G, H
RegeneronC, I/G, H
FoveaA/H
OphthotechC/H
Jennifer I. Lim
GenentechSP/H
Mathew W. MacCumber
GenentechA, I/G, H
RegeneronA/H
AllerganA, I/G, H
OptosA, I/G, H
GlaxoSmithKlineI/G
Tamer H. Mahmoud
AllerganA/H
Colin A. McCannel
ThrombogenicsA/H
GenentechI/G
SavvientB, SH/NC
Alimera SciencesC/H
William F. Mieler
GenentechC/H
AlconC/H
AllerganC/H
QLT/NovartisC/H
Alimera SciencesC/H
Virgilio Morales-Canton
orayaC/H
bayerA, SP/H
DorcSP/NC
Andrew A. Moshfeghi
Genentech, Inc.A, C/H
Allergan, Inc.A, C/H
Alcon, Inc.A, C/H
Realm Global, LLCB/SO
Convene, LLCB, F/ST
Thrombogenics, Inc.A, C/H
Darius M. Moshfeghi
Oraya TherapeuticsA, C, SP, SH/H, SO
SynergeticsA/H
IntraVista, LLCF/IP
OcuBell, Inc.F/ST
InSitu Therapeutics, Inc.C/IP, ST
Convene, LLCF/IP
Thrombogenics, Inc.A/H
Timothy G. Murray
AlconC/H
ThromboGenicsC/H
Kirk H. Packo
Alcon Surgical, IncA, C, SP/G, H, S
AllerganI/G
OD-OS, IncI/G
GenentechO/G
Peter Reed Pavan
GenentechI/G
GlaxoSmithKlineI/G
RegeneronI/G
AllerganI/G
SantenI/G
AlconI, O/E, G
PfizerI/G
ZeissO/E
Dante Joseph Pieramici
GenentechA, C, I/G, H
ThrombogenicsA, I/G, H
AllerganI/G
AllimeraA, SP/H
John S. Pollack
AlimeraC/H
Abbot Medical OpticsA/H
Clarus Acuity GroupB, F, SH/ST
Covalent MedicalB, SH/ST
Jonathan L. Prenner
OphthotechC, SH/OB, SO
PanopticaC/S
NeovistaC/SO
RegeneronC/S
GenentechC/S
NeurotechO/S
Narsing Rao
Xoma (US) LLCA/H
Carl D. Regillo
GenentechC, I, SP/G, H
RegeneronC, I, SP/G, H
GSKC, I/G, H
OphthotechI/G
Second SiteI/G
ACTI/G
AMOA, C/H
AlconC, I/G, H
AllerganC, I/G, H
AcucelaC, I/G, H
Kourous A. Rezaei
AlconO/G, H
GenentechO/G, H
BMCC/H
Alimera SciencesA/H
ThrombogenicsA/H
RegeneronO/G
Philip J. Rosenfeld
AcucelaC/H
AlexionI/G
Canon, Inc. A/H
Chengdu Kanghong BiotechC/H
GlaxoSmithKlineI/G
Oraya: ConsultantC/H
ThromboGenicsA/H
Carl Zeiss MeditecI, SP/G, H
SucampoA/H
DigisightSH/SO
Edwin H. Ryan
AlconC/IP
Srinivas Reddy Sadda
OptosC, I/G, H
OptovueI/G
Heidelberg EngineeringA/H
Carl Zeiss MeditecC, I/G, H
Topcon Medical SystemsO/R
AllerganC, I/G, H
GenentechA, I/G, H
ElanA/H
Lawrence J. Singerman
NIHI/G
OphthotechI/G
GlaxoSmithKlineI/G
NovartisI/G
AllerganI/G
Arctic Dx, IncA/H
ValeantA/H
OHRO/SO
Rishi P. Singh
ZeissA/H
GenentechC/H
Bausch and LombC/H
RegeneronC/H
Richard F. Spaide
TopconO/R
ThrombogenicsA/H
RegeneronO/G
Peter Stalmans
ThrombogenicsI/G
Bausch & LombI/G
FluoronI/G
DORCA/NC
EndoOptiksC/H
John T. Thompson
GenentechI/G
Regeneron PharmaceuticalsI/G
Trexler M. Topping
OMICB/H
NEII/G
AllerganC/H
Michael T. Trese
Nu-Vue TechnologiesC, F/IP
SynergeticsC/E
ThrombogenicsC, F/IP
FocusROPC, F/IP
Retinal Solutions LLCC, F/IP
GenentechC/H
Rohit Varma
AllerganC/H
AqueSysC/H
GenentechC, I/G, H
Merck & Co. Inc.C/H
ReplenishC, I/G, H
National Eye InstituteI/G
George A. Williams
Alcon Laboratories, Inc.C, O/G, S
Allergan, Inc.C, O/G, H
ForSightC, O/SO
NeurotechC/G
Nu-Vue Technologies, Inc.O/ST
OMIC-Ophthalmic Mutual Insurance CompanyE/S
OptiMedicaC, O/ST
ThromboGenicsC/S
Kang Zhang
Back to Top

Presenters
Financial Interest or Relationship Disclosures
Thomas M. Aaberg Jr.
SynergeticsC/H, IP
AllerganA/H
Anina Abraham
Prema Abraham
LPathC/G
AlconC/G
AllerganC/G
GenentechC/G
RegeneronC/G
AlmeraC/G
SantenC/G
Dina Joy K Abulon
Alcon LabsE/E
Lloyd P. Aiello
genentechA/H
genzymeA/H
kalvistaF/ST
pfizerC/H
Eli lillyC/NC
Thomas A. Albini
AlconC/H
AllerganC/H
Bausch + LombC/H
GenentechO/G
Robert L. Avery
alconC, I, SP/G, H
AllerganC, I/G, H
GenentechC, I, SP/G, H
NovartisC, SH/H, ST
Notal VisionC/H
OphthotechC/H
ReplenishA, C, SH/IP, R, ST
RegeneronC, SH/H, ST
AlexionSH/ST
QLTC/H
I-Tech JV Development, LLC SH/ST
Carl C. Awh
Arctic DXA, C, SH/H, SO
Bausch+LombC, SP/H
KatalystA, SH/R, ST
GenentechC, I/G, H
SynergeticsA, C, SH/H, R
VolkC/H
ForSightC/H, SO
RegeneronC, I/H
Carl W. Baker
Bausch and LombSP/H
ArcticDxE/S
GenentechI/OB
Glaxo-Smith-KlineI/OB
AlimeraI/OB
Rubens Belfort
alconA, C/G, H
allerganC/H
Darren J. Bell
RegeneronI/OB
AllerganI/OB
AlconI/OB
NeoVistaI/OB
GenentechI/OB
SantenI/OB
OptosI/OB
DRCR.netI/OB
Michael D. Bennett
AlconC, I, SP/G, H
AllerganC, I/G
CentraSightC, I, SP/G, H
eyetechA, C, I, SP/G, H
RegeneronA/G
OptimedicaC, I, SP/G, H
GenentechA, C, I, SP/G, H
OptovueC, I, SP/G, H
OptosA, C/G, H
Alan R. Berger
AlconA, SP/H
BayerA/G, H
NovartisA/G, H
Brian B. Berger
AllerganC, I/OB
Alcon LaboratoriesI/OB
Glaxo Smith KlineI/OB
Iconic TherapeuticsI/OB
LPath IncorporatedI/OB
LuxBiosciencesC, I/OB
GenentechI/OB
NeoVista PharamaceuticalI/OB
PfizerI/OB
ThrombogenicsI/OB
Alimera SciencesC/NC
Maria H. Berrocal
AlconC, SP/H
Harit K. Bhatt
Eyetech/ValeantA/H
RegeneronSH/NC
Abdhish R. Bhavsar
RegeneronA/H
GenentechI/G
DRCR.netI/G
Ava K Bittner
QLT Inc.C/G, OB
Kevin J. Blinder
Bausch and LombC/H
GenentechSP/H
AllerganSP/H
SynergeticsSP/H
RegeneronC, SP/G
OcusoftC/H
David Booth
I-Tech Development JV, LLCF/ST
Francesco Boscia
AlconSP/H
AllerganA/H
AlimeraA/H
BayerA/H
NovartisA, SP/H
David S. Boyer
alconA, C, I, SP/G, H
allerganA, C, I, SP/G, H
allegroA, SH/H
genentechC, I, SP/G, H
regeneronC, I/G, H
iCoC, I/NC
GSKC/H
NovartisC, I/G, H
BayerC/H
QuarkI/G
Michael H. Brent
Novartis CanadaA/G, H
Bayer CanadaA/H
Neil M. Bressler
Abbott Medical Optics Inc.I/G
Alimera SciencesI/G
Allergan USA, Inc.I/G
Bausch & Lomb IncorporatedI/G
Bristol-Meyers Squibb CompanyI/G
Carl Zeiss Meditec, Inc.I/G
DIAGNOS INCI/G
ForSight Labs, LLCI/G
Genentech, Inc.I/G
Genzyme CorporationI/G
Lumenis, Inc.I/G
Notal VisionI/G
Novartis Pharma AGI/G
Optovue, Inc.I/G
Pfizer, Inc.I/G
Quark Biotech, Inc.I/G
Regeneron Pharmaceuticals, Inc.I/G
Research to Prevent BlindnessI/G
Steba Biotech S.A.I/G
The EMMES CorporationI/G
David M. Brown
Genentech/RocheA, C, I/G, H
RegeneronA, C, I/G, H
AllerganA, C, I/G, H
AlconA, C, I/G, H
Gary C. Brown
Center for Value-Based MedicineF/NC
Brandon G. Busbee
GenentechA, C, I, SP/H
RegeneronSP/H
SynergeticsC/H
ThrombogenicsA/H
ElanA/H
AkornSH, O/R
AlimeraA/H
Melissa Cable
alconC/H
istaC/H
allerganC/H
bausch and lombC/G
David Callanan
AlconC/H
AllerganA/H
Bausch & LombC/H
ForsightC/H
Antonio Capone
AlconC/H
Alimera SciencesC/H
AllerganA, C/G, H
FocusROP, LLCF/IP
GenentechA, C/G, H
GlaxoSmithKlineC/G
OphthotecC/G
AcucelaC/G
Retinal Solutions, LLCF/IP
SynergeticsC/H, IP
ThrombogenicsC/G
Alessandro A Castellarin
genentechI, SP/H
AlconSH/NC
allerganI/OB
regeneronI/OB
Clement K. Chan
Allergan, Inc.A/OB
Alimera SciencesA/H
Genentech, IncC, I/G
National Eye InstituteI/E, G
Regeneron Pharmaceuticals, IncA, I/G, H
ThromboGenicsA, I/H
Owen Locke FoundationI/G
Stanley Chang
Alcon LaboratoriesA/H
Alimera SciencesC/H
Tom S. Chang
ThrombogenicsA/H
Johnson and Johnson Stem Cell OrgA, C/E, G, H
iScienceA, C/E, G, H
GenentechA/H
SynergeticsC/NC
Martin Charles
AlconA/H
Steve T. Charles
Alcon LaboratoriesC/NC, R
Nauman A. Chaudhry
GenentechI/OB
Sanford Chen
AlconA, C, I/H
AlimeraA, I/H
AllerganA/H
EyetechA/H
GenentechA, I, SP/H
RegeneronA, I, SP/H
ThromboGenicsA/H
Victor Chong
NovartisA, C, I, SP/G, H
PfizerA, C, I/G, H
BayerA, C, I, SP/H
AllerganA, C, SP/H
Alimera SciencesA/H
IridexA, SP/E, H
HeidelbergSP/H
Thomas Gerald Chu
Alcon SurgicalC/H
GenentechSP/H
Regeneron SP/H
Artur V. Cideciyan
QLTI/G
Shoshana Colman
GenentechE/S, ST
Stan Conston
iScience InterventionalE, F/S, SO
Stephen Couvillion, MD
GenetechA/H
Kent R. Crews
Alcon LabsA/H
GenentechI/NC
Karl G. Csaky
GenentechA, C, I, SP/G, H
Heidelberg EngineeringA/H
QLTA, C/H
NovartisC/H
AcucelaA, C/H
OphthotechC/H, SO
Lyndon da Cruz
PfizerO/E
Second Sight Medical Instruments Inc.O/E
G. Dagnelie
Second Sight Medical ProductsC/H
Mark Danese
Genentech, Inc.C, I/G
Michael J. Davis
SynergeticsC/H
AllerganA, C/H
Shelley Day
GenentechC/OB
Marc D. de Smet
AllerganA, C, SP/H
ThrombogenicsA, C/G, H, ST, SO
Janssens PharmaceuticalsC/H
Charles Rivers LabsI/H
BayerA, O/OB
RegeneronO/OB
SKFA/H
Vincent A. Deramo
AllerganI/G
Vincent Deramo
AllerganI/G
Quan Doan
GenentechC/G
AllerganC/G
David G. Dodwell
AllerganA, I/H, OB
NovartisI/OB
Chantal Dolan
GenentechC/S
Pravin U. Dugel
Abbott C/H
AlconC/H
AllerganC/H
Artic DxC, SH/H, ST
GenentechC/H
MacusightC, SH/H, ST
NeovistaC, SH/H, ST
ORA C/H
ThrombogenicsC/H
Regeneron C/H
Jay S. Duker
Hemera BiosciencesF/ST
OphthotechC/ST
EyeNetraC/ST
Paloma PharmaceuticalsA/NC
EMD/SeronoC/H
GenentechC/H
AlconC/H
RegeneronC/H
ThrombogenicsC/H
Carl Zeiss MeditechO/E
TopconO/E
OptoVueO/E
NeovistaA/H
NovartisC/H
QLTC/H
Alexander M. Eaton
I-Tech JV Development Company, LLCF, I, SP, SH/IP, ST
IC LabsF, I, SP, SH/IP, ST
Eye O2 ScanF, I, SP, SH/IP, ST
Neuron SystemsA/SO
Revitalid, IncSH/ST
RegeneronI/OB
GenentechI/OB
AlconA, I/H
Stephanie M Ecker
Ocular Proteomics LLCE/S
Jason S Ehrlich
Genentech/RocheE, SH/S, ST, SO
Dean Eliott
AlimeraC/H
Bausch & LombC/H
GenentechC/H
GlaukosC/H
OphthotechC/H
ThrombogenicsC/H
Michael J. Elman
NotalI/G
Ohr PharmaceuticalsA, C, I/G, SO
GenentechC, SP/G, H
Michael Engelbert
GenentechC/H
BMSC/H
Sina Farsiu
Duke UniversityI/IP
Philip J. Ferrone
AlconI/OB
AllerganI/OB
GenentechA, C, I, SP/H, OB
RegeneronSP/H
E. Filley
Second Sight Medical ProductsC/G
Retina Foundation of the SouthwestE/RF
Retina Foundation of the SouthwestE/S
Howard F. Fine
GenentechA, C/H
AllerganA, C/H
Auris Surigcal RoboticsB, F, SH/IP
OphthotechC/H
Jennifer Fine
Genentech IncE/S, ST, SO
Mitchell S. Fineman
ThromboGenicsI/G
Physician Recommended NutriceuticalsC/H
James C. Folk
IDx LLCF/ST
William J. Foster
William Joseph FosterO/IP
K. Bailey Freund
GenentechA/H
RegeneronA/H
QLT, IncA/H
AlimeraA/H
ThromboGenicsA/NC
OptosA/H
SequenomI/NC
David Friedman
AlconC/H
Basuch + LombC/H
MerckC/H
PfizerC/H
QLT, IncC/H
Anne E. Fung
GenentechA, I/G, H
SantenA/H
ThrombogenicsA/H
AllerganA/H
SequenomA/H
Roberto Gallego-Pinazo
NovartisA/H
AllerganI/G
Carl ZeissC/G
AlconO/G
Reinaldo A Garcia
Sunir J. Garg
MD IntelisysSH/NC
GenentechI/G
RegeneronI/G
LuxI/G
Eye GateI/NC
AllerganSP/H
Ronald C. Gentile
GenentechI/G
AcucelaI/E, G
NIHI/E, G
RegeneronI/G
Sirion TherapeuticsI/G
University of WII/G
AllerganI/G
JoAnn A Giaconi
AllerganC/H
Bert M. Glaser
Ocular ProteomicsF, I/IP, ST
Christine R. Gonzales
AlimeraA/H
EyetechA/H
AllerganSP/NC
OphthotechI/G
Iconic TherapeuticsI/G
Victor Hugo Gonzalez
PfizerI/G
Regeneron PharmaceuticalsI, SP/G, H
Alimera SciencesI/G
Quark pharma.I/G
ThrombogenicsI/G
AlconI/G
GenentechA, I/G, H
JDRFI/G
Iconic TherapeuticsI/G
Gabriel M Gordon
Retina Health CenterC/S
California Retina ConsultantsC/S
Anju Goyal
Pfizer, IncSH/NC
Hospira, IncSH/NC
Kenneth B. Graham
AlconI/G
Robert J Greenberg
Second Sight Medical Products, Inc.B, E, F, SH/IP, S, ST
Giovanni Gregori
Carl Zeiss MeditecO/G, IP
Jeffrey G. Gross
ThrombogenicsA/H
RegeneronI/G
AlimeraA, I/G, H
Shailesh K. Gupta
Beaver VisitecC/H
Russell Hamilton
Salutaris Medical Devices, Inc. C, F, SH/S
Tarek S. Hassan
GenentechA, C/H
RegeneronA, C/H
EyetechA/H
QLTA, SP/NC
AllerganA/NC
Bausch & LombA, C/H
Insight InstrumentsC, O/H, IP
Arctic DxC, SH/SO
OptimedicaSH/SO
ThrombogenicsSP/NC
William Hauswirth
AGTCC, F/H
RetroSenseC/H
Jeffrey S. Heier
AcucelaC/OB
Alcon Laboratories, Inc.I/G
AlimeraI/G
Allergan, Inc.C, I/G, OB
Bausch LombC/OB
Bayer HealthcareC, I/G, OB
Endo Optiks, Inc.C/OB
Forsight LabsC/OB
Fovea PharmaceuticalsI/G
GENENTECHI/G
GenzymeC, I/G, OB
GlaxoSmithKlineI/G
Heidelberg EngineeringC/OB
Kato PharmaceuticalsC/OB
Lpath Inc.I/G
Neovista Inc.I/G
Notal VisionC, I/G, OB
Novartis Pharmaceuticals CorporationI/G
OpthotechC, I/G, OB
Paloma Inc.I/G
QLT OphthalmicsC/OB
RegeneronC, I/G, OB
SequenomC, I/G, OB
AerpioC, I/G, OB
Dutch OphthalmicC/OB
Kala PharmaceuticalsC/OB
KanghongC/OB
NicoxC/OB
Ohr PharmaceuticalC/OB
RocheC/OB
ThrombogenicsC/OB
XcoveryC/OB
Vertex PharmaceuticalsC/OB
Florian M Heussen
NovartisO/OB
Joshua C. Hines, B.S.
Ocular proteomics llcE/S
Allen C. Ho
AlconA, C/H
AllerganI/G
JanssenC/G
GenentechC/G, H
PalomaC/H
PRNB/SO
RegeneronA/G, H
ThrombogenicsA, C/G, H
Carol Hoang
Genentech IncE/S
Nancy M. Holekamp
AllerganA, C, I/G, H
GenentechA, C, SP/H
SequenomI, SP/G, H
Arctic DxI/G
Alimera SciencesC/H
RegeneronSP/H
J. Jill Hopkins
GenentechE/S, SO
Jason Hsu
Advanced Cell TechnologyI/G
Eyegate Pharmaceuticals, Inc.I/G
Genentech Inc.I/G
Glaxo Smith KlineI/G
Lux Biosciences, IncI/G
Notal Vision, LtdI/G
NeovistaI/G
Santen IncI/G
Juvenile Diabetes Research FoundationI/G
Johnson and JohnsonI/G
Suber S. Huang
SequenomA/H
Second SightC/H
Notal VisionC/H
Bausch &LombA/H
AlconSP/H
Jean-Pierre Hubschman
AlconC/G
Bret Hughes
AlconA, C, SP/H
AllerganA, C, SP/H
MerckI/G
GlaukosI/G
Mark S. Humayun
SECOND SIGHT MEDICAL PRODUCTSC, I, O/IP, ST
Dean Hung
Icon BioscienceE, SH/S, ST, SO
Joseph Izatt
Bioptigen, Inc.B, F, SH/R, ST
Rama D. Jager
OD-OSC/H
Leonard Joffe
Salutaris MDA, I/SO
Karen Joos
AllerganO/RF
J. Michael Jumper
Covalent MedicalF/R
Peter K. Kaiser
NovartisC/G, H
RegeneronA, C/G, H
BayerA, C/H
SKS Ocular LLCB, F, SH/ST
Arctic DxA, C/H
OphthotechC/H
GenentechC/G, H
OrayaC/H
Bausch and LombA, C/H
AllegroA, C/H
AlimeraC/H
InSituC/H
Richard S. Kaiser
OphthotechC/H
PanOpticaC/H
NeoVistaC/H
Jeffrey Kammer
AllerganA, C, SP/H
IridexC, SP/H
AlconSP/H
MerckI/G
Rahul N. Khurana
RegeneronA/H
GenentechA, C, SP/H
IScienceC/H
AllerganI/G
Daniel F. Kiernan
Regeneron/ BayerC/H
Gerhard F. Kieselbach
BayerSP/H
NovartisSP/H
oertliSP/H
AlconSP/H
Hyung Chan Kim
Judy E. Kim
AllerganA/H
Alimera SciencesA/H
GenentechA/H
Szilard Kiss
AllerganA, C, I, SP/G, H
OptosA, C, I, SP/G, H
GenentechA, I, SP/G
RegeneronA, I/G
AlimeraA, C, SP/H
John W. Kitchens
GenentechC, I, SP/H
RegeneronA, SP/H
OptosC/H
SynergeticsA, C, SP/E, H
AllerganC/H
Frank H.J. Koch
Insight Instruments Stuart, FLC, SP/OB
Robert K Koenekoop
QLT IncC/H
Gregg T. Kokame
GenentechA/H
RegeneronA/H
AllerganA/H
SantenA/H
AlimeraA/H
Arthur Korotkin
GenenechI/G
Jonathan Kowalski
Allergan Inc.E/S, ST, SO
Baruch D. Kuppermann
AllerganA, C, I, SP/G, H
AllegroA, C/SO
AlimeraA, C, I/G, H
GenentechC, I/G, H
GlaxoSmithKlineI/G
NovagaliA, C/H
NeovistaC/H
ThrombogenicsA, C, I/G, H
RegeneronC, I/G, H
FoveaA/H
OphthotechC/H
Shree K. Kurup
AllerganA, SP/NC
Forsight LabsC/G
RegeneronA/G, H
AbbottI/G
Lux BioA/G, H
Santen IncI/G
Phil Lai
GenentechE, SH/S, SO
Wai-Ching Lam
BayerA/H
AllerganSP/H
NovartisSP/H
Kha Le
GenentechE/S
Abraham Lee
GenentechC/G
David Lee
SEEI/G
NEII/G
CDC Trans Eye CenterI/G
Paul Lee
GenetechC/OB
PfizerC, SH/OB, ST
Glaxo Smith KlineSH/ST
MerckSH/ST
Thomas C. Lee
Endo OptiksA/NC
Yannek I. Leiderman
Alcon Laboratories, Inc.O/E
Jennifer I. Lim
GenentechSP/H
Kristie L. Lin
Johnson and JohnsonA/H
Steven G. Lin
GenentechI/G
RegeneronI/G
National Eye InstitueI/G
Owen Locke FoundationI/G
Sanjay Logani
Doctorsoft CorporationF/ST
Careen Lowder
AllerganA/H
Tong Lu
GenentechE/S
Jeffrey K. Luttrull
Iridex CorporationC/H
Mathew W. MacCumber
GenentechA, I/G, H
RegeneronA/H
AllerganA, I/G, H
OptosA, I/G, H
GlaxoSmithKlineI/G
Douglas L MacKenzie
University of ColoradoI/IP, NC
Joseph I. Maguire
GenentechA, SP/H
RegeneronSP/H
Tamer H. Mahmoud
AllerganA/H
Mauricio Maia
Kemin InternationalO/IP
James M. Maisel
ZyDoc Medical TranscriptionB, F, I, SH/G, IP, ST
James C. Major
AllerganC/H
RegeneronC/H
Terri Malone
Johnson and JohnsonE/S, ST, SO
Sam E. Mansour
IridexA, C, I, SP/E, H
Laurence J Marsteller
SalutarisMDB, E, F, SH/S
Diogo Souza Martins
Kemin IndustryB/IP
Colin A. McCannel
ThrombogenicsA/H
GenentechI/G
SavvientB, SH/NC
Alimera SciencesC/H
Calvin E. Mein
ThrombogenicsI/OB
Chiltern/QuarkeI/OB
DRCR NetworkI/OB
NovaritsI/OB
Pauline T. Merrill
RegeneronA/H
AbbottC, I/H
SantenI/G
William F. Mieler
GenentechC/H
AlconC/H
AllerganC/H
QLT/NovartisC/H
Alimera SciencesC/H
Anthony Thomas Moore
QLTC/G, H
Oxford BiomedicaC/H
Virgilio Morales-Canton
orayaC/H
bayerA, SP/H
DorcSP/NC
Andrew A. Moshfeghi
Genentech, Inc.A, C/H
Allergan, Inc.A, C/H
Alcon, Inc.A, C/H
Realm Global, LLCB/SO
Convene, LLCB, F/ST
Thrombogenics, Inc.A, C/H
Darius M. Moshfeghi
Oraya TherapeuticsA, C, SP, SH/H, SO
SynergeticsA/H
IntraVista, LLCF/IP
OcuBell, Inc.F/ST
InSitu Therapeutics, Inc.C/IP, ST
Convene, LLCF/IP
Thrombogenics, Inc.A/H
Mark Moster
Biogen IdecSP/H
Acorda TherapeuticsC/H
Timothy G. Murray
AlconC/H
ThromboGenicsC/H
Manish Nagpal
AlconA, SP/H
BayerA/H
HeidelbergSP/H
TOPCONSP/H
AllerganA, SP/H
Jeffrey Nau
GenentechE, SH/S, ST
Marcio B. Nehemy
NovartisC/H
AlconC/H
BayerC, SP/H
Mark H. Nelson
QLT, Inc.C, SP/H
Eyetech, Inc.C, SP/H
Heidelberg Engineering, Inc.SP/H
Novartis Pharmaceuticals, Inc. A, C, SP/G, H
Sequenom, Inc.SP/H
Quan Dong Nguyen
Bausch and LombA, C/H
SantenA/H
Lux BiosciencesA/G
GenentechA/G
Asha S.D. Nuthi
National Eye InstituteI/G
genentechI/G
regenereonI/G
owen locke foundationI/G
jaeryung oh
NovartisO/G
Scott C. Oliver
GenentechI/G
OphthotechI/G
ThrombogenicsI/G
American Cancer SocietyI/G
ArdeaC/S
Yusuke Oshima
Alcon Laboratories, Inc.A, SP/H
Carl Zeiss MeditecSP/H
D.O.R.C. International, B.V.SP/E, H
Synergetics, Inc.A, SP/E, H
Topcon Medical Laser SystemsA/H
Kirk H. Packo
Alcon Surgical, IncA, C, SP/G, H, S
AllerganI/G
OD-OS, IncI/G
GenentechO/G
Peter Reed Pavan
GenentechI/G
GlaxoSmithKlineI/G
RegeneronI/G
AllerganI/G
SantenI/G
AlconI, O/E, G
PfizerI/G
ZeissO/E
Joel Pearlman
GenentechA/H
Fernando M. Penha
Carl Zeiss MeditecI/G
BayerC/H
NovartisSP/H
AllerganC/H
Dante Joseph Pieramici
GenentechA, C, I/G, H
ThrombogenicsA, I/G, H
AllerganI/G
AllimeraA, SP/H
John S. Pollack
AlimeraC/H
Abbot Medical OpticsA/H
Clarus Acuity GroupB, F, SH/ST
Covalent MedicalB, SH/ST
Sicco Popma
Janssen R&DE/SO, ST, S
Somdutt Prasad
BayerC/OB
NidekC/OB
Bausch & LombA/H
NeovistaI/G
AllerganA/H
Jonathan L. Prenner
OphthotechC, SH/OB, SO
PanopticaC/S
NeovistaC/SO
RegeneronC/S
GenentechC/S
NeurotechO/S
Peter Presti
Vimetrics, LLCC, F/S, ST
Hugo Quiroz-Mercado
Allegro Ophthalmics, LLCA/OB
Melvin D Rabena
GenentechSP/H
Robin Ray
Abbott LaboratoriesSH/ST
Carl D. Regillo
GenentechC, I, SP/G, H
RegeneronC, I, SP/G, H
GSKC, I/G, H
OphthotechI/G
Second SiteI/G
ACTI/G
AMOA, C/H
AlconC, I/G, H
AllerganC, I/G, H
AcucelaC, I/G, H
Elias Reichel
HEMERA BIOSCIENCESF/ST
AKORNO/R
ALLERGANA, I/H
OPHTHOTECHC/ST
EMD/SERONOC/H
GLAXOSMITHKLINEC, I/H
NEOVISTAC/H, ST
REGENERONA, I, SP/H
GENENTECHC, I/H
PERCEPTIVE INFORMATICSC/H
OCULAR INSTRUMENTSO/R
EPSILON INSTRUMENTSO/R
THROMBOGENICSA, C, I/G, H
FALCK MEDICALA, I, O/G
ALIMERAA, I/G, H
Kourous A. Rezaei
AlconO/G, H
GenentechO/G, H
BMCC/H
Alimera SciencesA/H
ThrombogenicsA/H
RegeneronO/G
Flavio A. Rezende
Insight InstrumentsC/E
Synergetics IncC/E
Guillermo Rocha, MD
AlconA, SP/H
AMOA, SP/H
AllerganA, SP/H
Bausch + LombC, SP/H
ZeissSP/H
SigmaconSP/H
Adam H. Rogers
Hemera BiosciencesB, F, SH/NC
Steven J. Rose
Bausch & LombA, SP/H
RegeneronI/NC
AllerganI/NC
GenentechI/NC
Richard B. Rosen
Optos-OPKO-OTIC/H
ClarityC/H
OD-OSC/H
TopconSP/H
GenentechI/G
AllerganI/G
AlimeraC/H
Philip J. Rosenfeld
AcucelaC/H
AlexionI/G
Canon, Inc. A/H
Chengdu Kanghong BiotechC/H
GlaxoSmithKlineI/G
Oraya: ConsultantC/H
ThromboGenicsA/H
Carl Zeiss MeditecI, SP/G, H
SucampoA/H
DigisightSH/SO
Daniel B. Roth
AllerganC, SP/H
GenentechC, SP/H
RegeneronA, C, SP/H
QLTA, SP/H
Forsight LabsC, SH/ST
Alan J. Ruby
genentechSP/H
Stephen R. Russell
IDx LLCF/IP
Edwin H. Ryan
AlconC/IP
Srinivas Reddy Sadda
OptosC, I/G, H
OptovueI/G
Heidelberg EngineeringA/H
Carl Zeiss MeditecC, I/G, H
Topcon Medical SystemsO/R
AllerganC, I/G, H
GenentechA, I/G, H
ElanA/H
Michael A. Samuel
Iscience InterventionalC/H
Johnson & JohnsonA, C/H
David A. Saperstein
QLT IncC/H, SO
RetinagenixB, F/IP, R, ST
Reid F. Schindler
SalutarisMDA, I/NC, SO
Hendrik P Scholl
QLT Inc.A/NC
Steven D. Schwartz
GenentechA/G, H
OptosA/E
AllerganC/G
AlconC/H
Bausch & LombSP/H
J. Sebag
ThromboGenicsC, SH/H
Chirag P. Shah
Alcon LaboratoriesI/G
Alimera SciencesI/G
Allergan, IncI/G
GenentechI/G
GenzymeI/G
Glaxo Smith KlineI/G
Molecular PartnersI/G
Neovista, Inc.I/G
Paloma PharmaceuticalsI/G
Regeneron PharmaceuticalsI/G
Fovea PharmaceuticalsI/G
Bayer PharmaceuticalsSP/H
Gaurav K. Shah
AlconC/E
AllerganC/E
QLTC/E
DORCC/E
Paul A. Sidoti
NeoMedix, Inc.SP/H
Stephen H. Sinclair
Vimetrics, LLCB, F, I, SP, SH/IP, NC
Michael A. Singer
GenentechI, SP/G, H
Allergan, Inc.A, C, I, SP/G, H
DRCRnetI, O/G, NC
NeovistaI, O/G, NC
IstaI/G
OptosI/E, NC
RegeneronI/G
Bausch and LombA, SP/H
Rishi P. Singh
ZeissA/H
GenentechC/H
Bausch and LombC/H
RegeneronC/H
Jason S. Slakter
AcucelaC, O/G, H
AlimeraO/G
AllerganO/G
Bayer HealthCareO/G
CorceptC, O/G, H
GenentechO/G
GlaxoSmithKlineO/G
Kanghong BiotechO/G
LpathO/G
NeoVistaO/G
NovagaliO/G
NovartisO/G
OxigeneO/G
PfizerO/G
RegeneronC, O/G, H
RevisionO/G
Sanofi-AventisO/G
OrayaC, O/G, H
SKS Ocular, LLCF/IP, ST
Elliott H. Sohn
Deallus Consulting GroupC/H
Richard F. Spaide
TopconO/R
ThrombogenicsA/H
RegeneronO/G
Sunil Srivastava
Bausch and LombA/G, H
AllerganO/G
NovartisO/G
Baldassarre Stea
SalutarisMDA, C, I/NC, SO
Gary Sternberg
GenentechE/S, ST, SO
Luis M. Suarez Tata
Homayoun Tabandeh
AlconC/H
AllerganA/H
John T. Thompson
GenentechI/G
Regeneron PharmaceuticalsI/G
Trexler M. Topping
OMICB/H
NEII/G
AllerganC/H
Cynthia Ann Toth
Alcon LaboratoriesO/IP
BioptigenO/E
GenentechO/G
Physical Sciences IncorporatedC, O/G
Michael T. Trese
Nu-Vue TechnologiesC, F/IP
SynergeticsC/E
ThrombogenicsC, F/IP
FocusROPC, F/IP
Retinal Solutions LLCC, F/IP
GenentechC/H
Lisa Tuomi
Genentech, Inc.E/S, SO
Adam Turpcu
GenentechE, SH/S, ST, SO
Rohit Varma
AllerganC/H
AqueSysC/H
GenentechC, I/G, H
Merck & Co. Inc.C/H
ReplenishC, I/G, H
National Eye InstituteI/G
Mario R. Ventresca
NovartisA/H
Jennifer E Visich
GenentechE/S
Hussein Wafapoor
ARMS LLCF/NC
Alexander Craig Walsh
Envision Diagnostics, Inc.B, E, F, SH/S, ST
Robert C. Wang
Systeem Medical Information Systems,LLCI/OB
John A. Wells
GenentechI/G
RegeneronI/G
StebaI/G
OphthotechI/G
IconicI/G
LpathI/G
NovartisI/G
PfizerI/G
EyetechA/H
Harold M. Wheatley
ThrombogenicsI/NC
RegeneronI/NC
GenentechI/NC
QuarkI/NC
NotalI/NC
NovartisI/NC
George A. Williams
Alcon Laboratories, Inc.C, O/G, S
Allergan, Inc.C, O/G, H
ForSightC, O/SO
NeurotechC/G
Nu-Vue Technologies, Inc.O/ST
OMIC-Ophthalmic Mutual Insurance CompanyE/S
OptiMedicaC, O/ST
ThromboGenicsC/S
Patrick Dewey Williams
RegeneronC/H
Paul Williamson
Johnson & JohnsonE/S
David T.W. Wong
NovartisA, C/H
BayerA, C/H
DiagnosC/OB
AllerganA, C/H
Pamela Wong
GenentechE/S
Tien Yin Wong
AbbottA/H
AllerganA/H
BayerA/H
NovartisA/H
PfizerA/H
RocheA/H
Vernon Wong
Icon Bioscience IncF/IP
Charles C. Wykoff
RegeneronSP/H
GenentechSP/H
Ron Yamamoto
iScience Interventional CorporationE/S, SO
Linda Yau
Genentech, Inc.E, SH/S, ST, SO
Steven Yeh
AbbottI/G
NovartisI/G
Wei-Shi Yeh
AllerganE/S
Zohar Yehoshua
Carl Zeiss MeditecO/G
Jiameng Zhang
GenentechE/S
Kang Zhang
Ingrid E. Zimmer-Galler
EyeTel Imaging, Inc.O/G
Eberhart Zrenner
QLT IncC/G, H
Back to Top